Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Identify which cards offer the highest cash back. This guide will help you maximize your rewards on everyday spending.
26,208 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A 61-year-old, single retiree with $640,000 saved faces a tight cash flow as they plan to retire at 62 while supporti...
A little-known income ETF has doubled this year by selling covered calls on AMD, outperforming the broad market as th...
Insider sales in biotech can spark questions about a company’s future. This guide breaks down what to watch, how to r...
A healthy 65-year-old with a family history of long life confronts Social Security timing beyond the classic break-ev...
Rivian’s quality metrics, limited service footprint, and steep pricing are prompting investor caution in 2026. This r...
C3.ai reports after the bell, with traders watching for signals on revenue, margins and AI platform uptake. This live...
Universal Corp misses EPS and swings to a loss in the third quarter, triggering a double-digit stock drop. Analysts f...
Analysts issued a fresh round of high-conviction calls Wednesday, spotlighting Arm Holdings, BorgWarner, GM, Mondelez...
EMB holds near the high end of its range as volatility fades, but a shift in the 10-year yield, policy signals, or EM...
Crypto traders are pricing SpaceX ahead of any IPO using Hyperliquid's SPCX-USDC contract, with early data suggesting...
U.S. homeowners hold record equity, but rising borrowing costs and cautious finances are keeping many from drawing on...